...
机译:鉴定与肾细胞癌中的日光尼抗性相关的突变
Department of Experimental OncologyEuropean Institute of Oncology (IEO)Milan Italy;
Department of OncologyClinica Universidad de NavarraPamplona Spain;
Bioinformatics Unit Center for Applied Medical Research (CIMA) IDISNAUniversity of;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Department of Experimental OncologyEuropean Institute of Oncology (IEO)Milan Italy;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Department of OncologyClinica Universidad de NavarraPamplona Spain;
Department of OncologyClinica Universidad de NavarraPamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Department of OncologyClinica Universidad de NavarraPamplona Spain;
Department of OncologyClinica Universidad de NavarraPamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Department of Diagnostic Pathology and Laboratory Medicine Fondazione IRCCSIstituto Nazionale dei;
Department of Diagnostic Pathology and Laboratory Medicine Fondazione IRCCSIstituto Nazionale dei;
Department of Diagnostic Pathology and Laboratory Medicine Fondazione IRCCSIstituto Nazionale dei;
Bioinformatics Unit Center for Applied Medical Research (CIMA) IDISNAUniversity of;
Health Research Institute of Navarra (IDISNA)Pamplona Spain;
Department of OncologyClinica Universidad de NavarraPamplona Spain;
sunitinib; renal cell carcinoma; biomarkers; resistance; MCL‐1; mTORC1; G6PD; LRP1B; SETD2; TET2; SYNE1; DCC;
机译:鉴定与肾细胞癌中的日光尼抗性相关的突变
机译:识别肾细胞癌细胞患者抗晒锡的微大研
机译:鉴定MEK1(F129L)激活突变是在携带B-RafV600E突变的人类癌症中获得获得的对MEK抑制的抗性的潜在机制。
机译:鉴定急性淋巴细胞白血病细胞中固有或获得抗泼尼松龙机制的比较计算方法
机译:Ror2作为肾癌细胞中的肿瘤癌细胞特异性激酶的鉴定与表征。
机译:获得性肿瘤细胞对舒尼替尼的耐药性在HT-29人结肠癌异种移植小鼠模型中引起耐药性而不会影响舒尼替尼的生物分布或肿瘤微脉管系统
机译:鉴定与肾细胞癌中的日光尼抗性相关的突变